Dr. Fama on GBV-C Infection and Risk of Lymphoma

Video

Angelo Fama, MD, Division of Hematology, Mayo Clinic, discusses a case control study of the GB Virus-C (GBV-C) infection and the risk of lymphoma.

Angelo Fama, MD, Division of Hematology, Mayo Clinic, discusses a case control study of the GB Virus-C (GBV-C) infection and the risk of lymphoma.

According to Fama, after several studies it was demonstrated that the GBV-C infection is replicated in the B and T cells.

After the case-controlled study, it was shown that there was an association between GBV-C and risk for each major lymphoma subtype excluding Hodgkin lymphoma and chronic lymphocytic leukemia (CLL), states Fama.

<<<

More from the International Conference on Malignant Lymphoma

Related Videos
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Alessandra Ferrajoli, MD
Pasi A. Jänne, MD, PhD, discusses an exploratory analysis from the FLAURA2 trial of osimertinib plus chemotherapy in treatment-naive, EGFR-mutant NSCLC.
Eric S. Christenson, MD
Samer A. Srour, MB ChB, MS
Dipti Patel-Donnelly, MD, Johns Hopkins
Rebecca L. Porter, MD, PhD
Deborah J. Wong, MD, PhD